The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer-Reference-Cited by-同舟云学术

The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer

Published:2006-05 Issue:2 Volume:101 Page:238-243
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Malander Susanne,Rambech Eva,Kristoffersson Ulf,Halvarsson Britta,Ridderheim Mona,Borg Åke,Nilbert Mef

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference39 articles.

1. Cancer statistics, 2000;Greenlee;CA Cancer J. Clin.,2000

2. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer;Ziogas;Cancer Epidemiol. Biomarkers Prev.,2000

3. Hereditary ovarian cancer;Prat;Hum. Pathol.,2005

4. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer;Risch;Am. J. Hum. Genet.,2001

5. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing;Rubin;Am. J. Obstet. Gynecol.,1998

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Counselling and management of women with genetic predisposition to gynaecological cancers;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-03

2. Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements;International Journal of Molecular Sciences;2024-02-03

3. Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome;Cancers;2023-12-08

4. Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes;Translational Research;2023-10

5. Genomic testing in high-grade serous ovarian cancer: current options and future development;International Journal of Gynecologic Cancer;2023-03